Cuprina Holdings

Singapore-based MedTech company that specialises in the development of products to treat chronic wounds. MEDIFLY, a bio-dressing made of live, medical-grade maggots, is used by private and public hospitals in Singapore and Hong Kong to disinfect and debride chronic wounds, known as Maggot Debridement Therapy (MDT). Our product is clinically-proven to reduce amputation rates and eliminate infections in chronic wounds, especially diabetic foot ulcers and pressure ulcers. We are ISO13485 certified and our MEDIFLY products are HSA registered as class C medical devices.